Advertisement

Advertisement

2021 MASCC/ISOO Annual Meeting

Pain Management

By Meg Barbor, MPH / September 10, 2021 / 2021 MASCC/ISOO Annual Meeting

Study Finds Evidence-Based Interventions Added to Screening Did Not Improve Cancer Pain

When added to regular screening and guidelines, evidence-based interventions implemented at the patient, health professional, and service levels did not significantly improve cancer pain, according to...

Supportive Care

Pain Management

By Meg Barbor, MPH / September 10, 2021 / 2021 MASCC/ISOO Annual Meeting

Early-Phase Study Rediscovers Potential Alternative to Methadone for Cancer Pain

Levorphanol was associated with improved pain and symptom control in patients with advanced cancer, according to data from an early phase I trial, reported by Akhila Reddy, MD, at the 2021 Multination...

Advertisement

Advertisement

Nov

21

Today In Oncology

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma

Neuro-Oncology Guidelines Reveal How AI Could Improve Brain Cancer Diagnosis Monitoring and Treatment

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

Advertisement

© 2024 HSP News Service, L.L.C.